Allopurinol Tablet
Product Images NDC 16714-577

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 16714-577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-1000s-cont-label (100mg 1000s Cont Label)

100mg-1000s-cont-label (100mg 1000s Cont Label)
This is a medication package containing 1000 tablets of ALLOPURINOL, manufactured by Idoco Remadios L. The tablets should be stored in a dry place at 10-25°C and dispensed in light-resistant packaging. The package has a NDC number of 1671457604. It also has information on the manufacturer's address but no other relevant details are provided.*
FDA Label Image

100mg-100s-cont-label (100mg 100s Cont Label)

100mg-100s-cont-label (100mg 100s Cont Label)
This is a medication called Allopurinol, with NDC 16714-576-02, manufactured by Indoco Remedies Ltd. in India and distributed by Northstar Rx LLC in the US. The medicine comes in tablet form, with each scored tablet containing 100mg of Allopurinol USP. It is recommended to store it in a dry place at 20-25°C and to keep it out of reach of children. For further information about usage, dosage and precautions, please refer to the accompanying package insert.*
FDA Label Image

100mg-30s-cont-label (100mg 30s Cont Label)

FDA Label Image

100mg-500s-cont-label (100mg 500s Cont Label)

100mg-500s-cont-label (100mg 500s Cont Label)
This is a description of Allopurinol, a medication that comes in tablet form. These tablets come in a container with 500 tablets. The dosage, precautions, and indications are mentioned in the accompanying package. The manufacturer of the tablets is Doco Remados L. The code for the medicine is NG 1671457603. The document also includes some storage instructions, such as keeping the tablets in a dry place at room temperature. It also mentions a code, R 102021, and a mention of a manufacturing company. However, the text is partially illegible.*
FDA Label Image

300mg-100s-cont-label (300mg 100s Cont Label)

300mg-100s-cont-label (300mg 100s Cont Label)
ALLOPURINOL is a medication that comes in a tablet form. Each scored tablet contains 300 mg of Aloputinal. It is important to keep it stored in a dry place, in a USP Controlled Room Temperature of 68° to 77°F. The medication should be dispensed in a light-resistant container, as defined in the USP. It is manufactured by Novadoz Pharmaceuticals LLC, located in Tennessee, USA. The dosage, indications, and precautions for the medication can be found in the accompanying package insert. The product code for the tablets is GOIDRUGS 55, with NDC number 1671457701. This medication is not suitable for children and should be kept out of their reach.*
FDA Label Image

300mg-500s-cont-label (300mg 500s Cont Label)

300mg-500s-cont-label (300mg 500s Cont Label)
This is a medication called Allopurinol, which comes in a 300 mg tablet form. The recommended storage temperature is between 20-25°C. The package includes resistant tablets with USP defined container for indications, dosage, and precautions. The package should be accompanied by a packaging insert. The remaining text is not readable.*
FDA Label Image

Allopurinol-ros (Allopurinol Ros)

Allopurinol-ros (Allopurinol Ros)
Allopurinol and Oxipurinol are drugs used to treat conditions related to high levels of uric acid in the body such as gout. The chemical structures of these drugs and the compounds they act on, including Hypoxanthine, Xanthine, and Uric acid are presented using their molecular formulas.*
FDA Label Image

Allopurinol-struct (Allopurinol Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.